News

 

Fortimedix advances a differentiated symphonX™ ENT product line

Following exploratory surgery with the symphonX™ Surgical Platform in March 2018, Dr. Joseph Califano, Professor of Surgery and Vice Chief of Otolaryngology / Head & Neck, and his colleagues Dr. Philip Weissbrod and Dr. Ryan Orosco at UC San Diego Health, successfully completed initial pre-clinical testing of a new dedicated product line for laryngopharyngeal surgery.
Read the full article

First TaCR Clinical Experience With symphonX™ Based Platform

In 2018, Dr. Karl-Hermann Fuchs, Chief of Surgery at the Agaplesion Markus Hospital, Frankfurt am Main successfully completed a series of hybrid transanal colon resection (TaCR) cases with an increasing number of procedural steps performed transanally with the symphonX™ based platform.
Read the full article

Successful Pre-clinical ENT Study Performed at UC San Diego CFS

In March, Dr. Joseph Califano, Professor of Surgery and Vice Chief of Otolaryngology / Head & Neck at UC San Diego Health, performed exploratory surgery of the oropharynx in a cadaveric model with the symphonX™ Surgical Platform.
Read the full article

Note: FMX314 is the engineering code name for symphonX™ used during the pre-commercial phase.

 Download our Media Kit here. For media inquiries, please contact Marc van de Graaf via +1(858) 414 4989 or via our media(at)fortimedix.com

Copyright © Fortimedix Surgical 2018. All rights reserved.

 

Stay updated about the latest developments and innovations from Fortimedix Surgical - subscribe to our newsletter via our subscription form.

 

By using our website you consent to all cookies in accordance with our Cookie Policy.